Cloned probes of herpes simplex virus type 2 DNA were used in cytological hybridization experiments to detect herpesvirus RNA transcripts in the neoplastic cells of tumors of the uterine cervix. Virus-specific RNA was shown to represent transcription of limited regions of the genome, of which one is known to code for a DNA-binding protein that can be found by immunoperoxidase staining in the neoplastic cells of these tumors and has also been detected in cells transformed in vitro by this virus.The thesis that the continuum of disease leading to the development of uterine cervical carcinoma is associated with prior infection by herpes simplex virus type 2 (HSV-2) (1-5) has recently been tested at the molecular level by the use of in situ cytological hybridization (6-9). The use of 3H-labeled viral DNAs as probes to detect virus-specific RNA (10, 11) in cervical tissue has resulted in general agreement, based on published reports, that at least 30% ofall cervical intraepithelial neoplasia (CIN) and cervical carcinoma tissues contain cells that bind a HSV-2 [3H]DNA probe but not probes representing other viral DNAs, indicating the presence of HSV-specific RNA (7-9). The majority of these in situ hybridizations have been conducted with whole genomic DNA as the probe. In this report we summarize our studies using cloned subgenomic fragments of HSV-2 DNA as hybridization probes to define regions of the virus genome from which the detected RNA species are transcribed and correlate the findings with attempts to identify viral antigen(s) expressed in cervical carcinoma cells.There have been numerous reports that antibodies to HSVspecific proteins are found more frequently, or at higher titer, in women with CIN or cervical carcinoma than in controls (12)(13)(14) and that HSV-specific antigens can be detected in the neoplastic cells by immunofluorescent or other methods (15)(16)(17). Among the abundance ofsometimes confusing data (18,19), two series of recent reports were of interest with respect to our in situ hybridization results. First, antiserum to the major HSV-2 binding protein (20) was shown to react with human cervical carcinoma cells in two separate studies (21,22). The tumor antigens of other DNA viruses have been shown, without exception, to have DNA-binding properties (23), and a herpes simplex tumor antigen might be expected to exhibit a similar function. Second, it was demonstrated that sera from patients with cervical carcinoma precipitated two HSV-2 polypeptides (with molecular weights 38,000 and 118,000) more frequently than did sera from controls (24).The 38,000-dalton protein was ofinterest because it has been shown that a protein of this size is encoded within Bgl II fragment N of HSV-2 DNA (25, 26), which has been reported to have transforming activity in rodent cells (27,28).Rodent cells transformed in vitro by HSV-2 have been reported to express a number of HSV-specific antigens including VP143 (29), ICP10 (30), thymidine kinase (31, 32), membrane glycoproteins gA/gB (33, 34), and CP-1 (35)...